Bar Plot from Scientific Research

GMRs to baseline (95% CI) of serum hs-CRP concentrations in the placebo and three clazakizumab dose groups and at week 12 after randomization are shown ( P < 0.001 for each of the clazakizumab dose groups versus placebo). Two-sided P values shown are from the MMRM analysis, using a t test, and are not adjusted for multiplicity. Number of patients are placebo ( n = 26); 2.5 mg ( n = 24); 5 mg ( n = 26); 10 mg ( n = 25). CI, confidence interval.

DOI